Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
SRRA

Sierra Oncology

$0.49

0.1035 (27.13%)

06:55
12/08/19
12/08
06:55
12/08/19
06:55
Conference/Events
Sierra Oncology to hold an analyst and investor event »

Analyst and Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

SRRA

Sierra Oncology

$0.49

0.1035 (27.13%)

04:55
12/08/19
12/08
04:55
12/08/19
04:55
Conference/Events
Sierra Oncology to hold an analyst and investor event »

Analyst and Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

SRRA

Sierra Oncology

$0.49

0.1035 (27.13%)

09:16
12/07/19
12/07
09:16
12/07/19
09:16
Hot Stocks
Sierra Oncology reports new analyses of momelotinib compared to ruxolitinib »

Sierra Oncology reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

COP

ConocoPhillips

$60.92

1.09 (1.82%)

, SRRA

Sierra Oncology

$0.46

0.0784 (20.55%)

10:04
12/06/19
12/06
10:04
12/06/19
10:04
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

COP

ConocoPhillips

$60.92

1.09 (1.82%)

SRRA

Sierra Oncology

$0.46

0.0784 (20.55%)

RST

Rosetta Stone

$15.75

0.52 (3.41%)

GTLS

Chart Industries

$55.49

2.47 (4.66%)

MGM

MGM Resorts

$32.11

0.17 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

  • 11

    Dec

  • 12

    Dec

SRRA

Sierra Oncology

$0.38

-0.04 (-9.52%)

16:10
12/05/19
12/05
16:10
12/05/19
16:10
Initiation
Sierra Oncology initiated at Oppenheimer »

Sierra Oncology initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

SRRA

Sierra Oncology

$0.50

0.1571 (46.03%)

07:45
12/03/19
12/03
07:45
12/03/19
07:45
Conference/Events
Sierra Oncology to hold an analyst and investor event »

Analyst and Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

SRRA

Sierra Oncology

$0.25

0.0095 (3.99%)

07:04
11/20/19
11/20
07:04
11/20/19
07:04
Hot Stocks
Sierra Oncology launches Momentum Phase 3 clinical trial in Myelofibrosis »

Sierra Oncology has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

SRRA

Sierra Oncology

$0.35

0.0262 (8.19%)

, GILD

Gilead

$65.41

0.01 (0.02%)

09:07
11/07/19
11/07
09:07
11/07/19
09:07
Hot Stocks
Sierra Oncology amends momelotinib purchase agreement with Gilead »

Sierra Oncology (SRRA)…

SRRA

Sierra Oncology

$0.35

0.0262 (8.19%)

GILD

Gilead

$65.41

0.01 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

SRRA

Sierra Oncology

$0.35

0.0262 (8.19%)

17:18
11/06/19
11/06
17:18
11/06/19
17:18
Syndicate
Sierra Oncology announces offering of convertible preferred stock, warrants »

Sierra Oncology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

SRRA

Sierra Oncology

$0.35

0.0305 (9.56%)

16:04
11/04/19
11/04
16:04
11/04/19
16:04
Earnings
Sierra Oncology reports Q3 EPS (17c), consensus (21c) »

Cash and cash equivalents…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.